Christine Lin

Professor Christine Lin is a leading academic at the Institute for Musculoskeletal Health, affiliated with the Sydney School of Public Health and Faculty of Medicine and Health at The University of Sydney. With over $15 million in research funding and 170+ publications in prestigious journals, her work focuses on improving care for musculoskeletal pain conditions, particularly through clinical trials and systematic reviews on opioid deprescribing and treatment optimization.

• PhD in 2008 from The University of Sydney
• Professional background in physiotherapy
• Affiliated with Sydney Musculoskeletal Health and Sydney Local Health District

Her research highlights the limited efficacy and risks of opioids for back pain, influencing clinical guidelines globally. She has led major trials like the OPAL Trial and developed frameworks for evidence-based opioid deprescribing. Key themes include Healthy Ageing and Lifespan Musculoskeletal Care, with methodological expertise in Clinical Trials and Rehabilitation.

Recent publications analyze trends in opioid prescription and non-pharmacological interventions for pain management. Awards include the STInG Excellence in Trial Statistics Award (2018) and finalist status in the Australian Clinical Trials Alliance Trial of the Year. She mentors PhD students and leads initiatives to reduce opioid-related harms while advancing rehabilitation strategies.